-
Developments in breast cancer: What’s new from SABCS 2025
22 Dec 2025 19:07 GMT
… cancer has remained stable for over a decade, with Taxol … cancer has one of the most successful precision medicine … cancer research, cytotoxic free regimens, first line treatment, … , metastatic breast cancer, palbociclib, PATINA trial, pertuzumab, progression …
-
S2 Episode 3: Management of Metastatic HER2-Positive Breast Cancer
18 Dec 2025 15:28 GMT
… the Department of Medicine at Harvard Medical School and chief … trial, which we hoped would replace chemotherapy with an antibody-drug … the designs of those trials is going to have … Versus Standard Treatment (ddAC-THP), in HER2-Positive Early Breast Cancer
-
Pyrazoline B Induces Oxidative Stress Mediated Toxicity, Cell Cycle Arrest, and Caspase-Independent Apoptosis in BT-474 Human Breast Cancer Cells
13 Dec 2025 10:08 GMT
… Treatment options for luminal B breast cancer include surgery, chemotherapy … Office under Post-Doctoral Batch II program, … international breast cancer study group trials VIII and … evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness …
-
Oncotelic Therapeutics Details PDAOAI Platform and Opens Access to Its Total TGF-β Knowledge Corpus
22 Dec 2025 13:00 GMT
… of clinical endpoints
Precision trial design and combination … drug development to improve treatment outcomes and survival of cancer … build an AI driven biotechnology company. Further, Oncotelic … approval to conduct clinical trials and upon granting of …
-
Cell nucleus shape plays a key role in cancer therapy outcomes
02 Dec 2025 17:48 GMT
… also explain why combining certain cancer drugs can produce the opposite of … that when Taxol and PARP inhibitors are combined in cancer treatment, the effect … resistant to treatment with PARP inhibitors. So, combining these drugs with each …
-
<![CDATA[Early ASP2138 Data Show Encouraging Activity and Improved Safety in Gastric, GEJ Cancer]]>
01 Dec 2025 23:01 GMT
… target in gastric and GEJ cancers. We have approval for … activity, as with many other drugs. Then, interestingly, they did … combined with our standard Taxol and ramucirumab chemotherapy. In frontline, it … and ramucirumab in phase 3 trials is more like 27– …
-
Could Carba1 Prevent Chemotherapy-Induced Neuropathy?
27 Nov 2025 04:53 GMT
… cancer treatment.
CIPN affects 70%-80% of patients receiving chemotherapy, … .”
She added, “Doctors sometimes have patients wear … Columbia University Irving Medical Center in New … larger pharmaceutical company capable of conducting clinical trials,” Lafanechère …
-
Mapping our deep-rooted relationship with medicinal plants
21 Nov 2025 19:16 GMT
… before modern pharmaceuticals, our … medications.
Madagascar periwinkle (Catharanthus roseus) was the source of the chemotherapy drugs … anticancer drug paclitaxel
otherwise known as Taxol.
Overall … of medicine — recommended some 300 plant remedies such …
-
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
17 Nov 2025 14:11 GMT
… e.g. paclitaxel (Taxol®) and docetaxel, in … pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment … trials as a monotherapy and in combination with bevacizumab for the treatment … and FDA engagement on the clinical trial for …
-
Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight
06 Nov 2025 23:45 GMT
… more about endometrial cancer treatment options, visit @ Approved Endometrial Cancer Drugs
Endometrial Cancer Competitive Landscape … Pharmaceuticals, AbbVie, Neurocrine Biosciences, ObsEva, Kissei Pharmaceuticals, SWK, Enteris BioPharma, Bayer, Hope Medicine …